[Translation] A randomized, double-blind, placebo-controlled, single-dose escalation Phase Ia clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of SGC001 in healthy Chinese adult subjects
评估SGC001在中国健康受试者中单次给药后的安全性和耐受性
[Translation] To evaluate the safety and tolerability of SGC001 after a single dose in healthy Chinese subjects